Mycenax Biotech Incorporated operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mycenax Biotech Incorporated with three other
companies in this sector in Taiwan:
Abnova (Taiwan) Corporation
sales of 475.07 million Taiwanese Dollars [US$16.21 million]
of which 100%
Genmont Biotech Inc
(552.94 million Taiwanese Dollars [US$18.87 million]
(562.74 million Taiwanese Dollars [US$19.21 million]
of which 99%
was Finished Products Sales).
Mycenax Biotech Incorporated reported sales of 318.64 million Taiwanese Dollars (US$10.88 million)
December of 2017.
increase of 58.8%
versus 2016, when the company's sales were 200.61 million Taiwanese Dollars.
Sales at Mycenax Biotech Incorporated have increased during each of the previous five years
(and since 2012, sales have increased a total of 793%).